FK 453

Drug Profile

FK 453

Alternative Names: FK 113453; FR 113453; FR 453

Latest Information Update: 23 Jun 1998

Price : $50

At a glance

  • Originator Fujisawa
  • Class Antihypertensives; Neuroprotectants; Small molecules; Vasodilators
  • Mechanism of Action Adenosine A1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure; Hypertension

Most Recent Events

  • 23 Jun 1998 Commercial data has been reviewed by Fujisawa
  • 23 Jun 1998 Discontinued-Preclinical for Heart failure in United Kingdom (PO)
  • 23 Jun 1998 Discontinued-Preclinical for Heart failure in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top